ISRAEL – Insightec, a Haifa, Israel and Miami, FL-based healthcare company dedicated to using acoustic energy to transform patient care, signed a credit facility for up to $200 million with affiliates of existing shareholders Perceptive Advisors and Community Fund.
The financing has provided Insightec with $100 million at closing, with an additional $100 million of financing potentially available in tranches through 2024. The credit facility is interest-only for five years and matures on August 31, 2027. The company intends to use the funds to drive adoption of incisionless neurosurgery to treat patients with Essential Tremor and Parkinson’s Disease, while continuing to advance innovation and clinical trials for expanded applications of its technology in neuro-oncology and other neurological conditions.Led by CEO Maurice R. Ferré, Insightec leverages the Exablate Neuro platform to provide sound waves, guided by MRI, to provide tremor treatment to patients with medication-refractory Essential Tremor and Parkinson’s Disease. Research for future applications in the neuroscience space is underway in partnership with leading academic and medical institutions. The company also has offices in Dallas, Shanghai, and Tokyo.01/09/2022
